These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [Echography in assessment of liver changes in children with different diseases]. Oskolkova MK; Dvoriakovskiĭ IV Vopr Okhr Materin Det; 1977; 22(2):12-7. PubMed ID: 841936 [No Abstract] [Full Text] [Related]
27. [Investigations involving the liver toxicity of Ro 6-2580]. Giese G Chemotherapy; 1969; 14():Suppl:66-70. PubMed ID: 5379873 [No Abstract] [Full Text] [Related]
29. [Antioxidant activity of hepatotropic preparations in the treatment of chronic diseases of the liver]. Loginov AS; Matiushin BN; Sukhareva GV; Tkachev VD Ter Arkh; 1988; 60(8):74-7. PubMed ID: 3227482 [TBL] [Abstract][Full Text] [Related]
30. [Controlled clinical trial of 5(4)-amino-4(5)-imidazole carboxyamide ureidosuccinate, a new hepatic therapeutic agent stimulating liver regeneration and protein anabolism]. Busin S; Micheli PL; Sovera A Clin Ter; 1977 Dec; 83(5):483-529. PubMed ID: 343971 [No Abstract] [Full Text] [Related]
31. [Sequental estrogen-progestogen treatment and hepatic function in the climacteric age]. Cazzola D Ann Ostet Ginecol Med Perinat; 1969 Nov; 91(11):756-73. PubMed ID: 5403945 [No Abstract] [Full Text] [Related]
32. [Use of "Essenciale" in the treatment of liver diseases]. Pogromov AP; Ol'binskaia LI; Antonenko NI; Gitel' NP; Smolianitskiĭ AIa Klin Med (Mosk); 1978 Oct; 56(10):97-101. PubMed ID: 362064 [No Abstract] [Full Text] [Related]
33. [Immunosuppressive treatment of chronic liver diseases in the clinical biochemical, immunological and histological evaluation of the liver]. Boroń P; Szpakowicz T; Bobrowska E; Boroń-Kaczmarska A; Prokopowicz D; Borzuchowska A Z Gesamte Inn Med; 1981 May; 36(10):318-21. PubMed ID: 7303757 [TBL] [Abstract][Full Text] [Related]
34. [Chronic liver damage in Ethiopic children following epidemic hepatitis]. Zic B; Weithaler K Wien Med Wochenschr; 1971 Jun; 121(24):501-3. PubMed ID: 5094456 [No Abstract] [Full Text] [Related]
35. [Use of levamisole, an immune controlling agent in various clinical conditions mainly liver diseases (author's transl)]. Miyake M Fukuoka Igaku Zasshi; 1981 Jun; 72(6):368-78. PubMed ID: 6975743 [No Abstract] [Full Text] [Related]
36. [Controlled double-blind study of the effects of cycloxilic acid on hepato-biliary function]. Rosselli M; Cavrini P Clin Ter; 1978 Sep; 86(5):465-84. PubMed ID: 367682 [No Abstract] [Full Text] [Related]
37. [On the problem of liver tolerance of a modern estrogen preparation]. Seifert E Med Welt; 1969 Feb; 8():427-30. PubMed ID: 5771342 [No Abstract] [Full Text] [Related]
38. [Problem of evaluation of liver function in children]. Bittner K; Socha J; Waligóra A Pol Tyg Lek; 1968 Apr; 23(17):623-5. PubMed ID: 5675162 [No Abstract] [Full Text] [Related]
39. [The anti-steatosic effect of sulfo-adenosylmethionine (SAMe) in various forms of chronic hepatopathy. Multicentric research]. Mazzanti R; Arcangeli A; Salvadori G; Smorlesi C; Di Perri T; Auteri A; Boggiano CA; Pippi L; Toti M; Boncompagni P; Angioli D; Caremani M; Magnolfi F; Camarri E; Motta R; Forconi A; Candidi Tommasi A; Lomi M; Soldi A Minerva Med; 1978 Oct; 69(48):3283-92. PubMed ID: 724140 [No Abstract] [Full Text] [Related]
40. [Can patients with liver diseases participate in sports? Standardized walking and swimming tests in 220 patients with acute and chronic liver diseases]. Müting D; Kalk JF; Bretscher C Fortschr Med; 1987 Apr; 105(12):233-6. PubMed ID: 3596437 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]